NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma

Cancers
Moinul HaqueRaymond Lai

Abstract

Forkhead Box M1 (FOXM1) is an oncogenic transcription factor implicated in the pathogenesis of solid and hematologic cancers. In this study, we examined the significance of FOXM1 in NPM-ALK-positive anaplastic large cell lymphoma (NPM-ALK + ALCL), with a focus on how it interacts with NPM-ALK, which is a key oncogenic driver in these tumors. FOXM1 was expressed in NPM-ALK + ALCL cell lines (5/5), patient samples (21/21), and tumors arising in NPM-ALK transgenic mice (4/4). FOXM1 was localized in the nuclei and confirmed to be transcriptionally active. Inhibition of FOXM1 in two NPM-ALK + ALCL cells using shRNA and pharmalogic agent (thiostrepton) resulted in reductions in cell growth and soft-agar colony formation, which were associated with apoptosis and cell-cycle arrest. FOXM1 is functionally linked to NPM-ALK, as FOXM1 enhanced phosphorylation of the NPM-ALK/STAT3 axis. Conversely, DNA binding and transcriptional activity of FOXM1 was dependent on the expression of NPM-ALK. Further studies showed that this dependency hinges on the binding of FOXM1 to NPM1 that heterodimerizes with NPM-ALK, and the phosphorylation status of NPM-ALK. In conclusion, we identified FOXM1 as an important oncogenic protein in NPM-ALK+ ALCL. Our re...Continue Reading

References

May 1, 1997·Nucleic Acids Research·W KorverH Clevers
Oct 30, 2001·FEBS Letters·T W LeungK M Yao
Jan 27, 2005·Journal of Cell Science·Richard Y M MaKwok-Ming Yao
May 24, 2007·Blood·Hesham M Amin, Raymond Lai
Oct 19, 2007·Nature Reviews. Cancer·Stephen S Myatt, Eric W-F Lam
Jun 6, 2008·The Journal of Biological Chemistry·I-Ching WangLester F Lau
Nov 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·Zhaoliang LiStephen R Hann
Dec 27, 2008·Methods in Molecular Biology·James LeeRenier Brentjens
Oct 7, 2009·Cell Cycle·Bulbul PanditAndrei L Gartel
Aug 24, 2011·Nature Chemistry·Nagaratna S HegdeShankar Balasubramanian
Oct 8, 2011·Biochimica Et Biophysica Acta·Chuay-Yeng KooEric W-F Lam
Oct 8, 2011·The Journal of Biological Chemistry·Uppoor G BhatAndrei L Gartel
Feb 22, 2013·Molecular Cancer Therapeutics·Zebin WangPradip Raychaudhuri
Nov 20, 2014·Journal of Visualized Experiments : JoVE·Stanley BorowiczRobert A Winn
Jan 6, 2015·Leukemia Research·Özlem TüfekçiYusuf Baran
Mar 11, 2015·Nature Communications·Maike BuchnerMarkus Müschen
Aug 25, 2016·BMC Molecular Biology·Joseph K BoxDerek J Richard
Dec 23, 2016·Nucleic Acids Research·Jianhuang LinMitsuru Okuwaki
Jan 24, 2017·Leukemia·E M HeathA D Schimmer
Aug 10, 2018·JCI Insight·Irum KhanAndrei L Gartel

❮ Previous
Next ❯

Citations

Apr 24, 2020·Seminars in Cancer Biology·Chakrabhavi Dhananjaya MohanKanchugarakoppal S Rangappa

❮ Previous
Next ❯

Methods Mentioned

BETA
gene knockdown
PCR
transfection
Immunoprecipitation
co-immunoprecipitation
nuclear
xenografts
ChIP
transgenic
Assay

Software Mentioned

GraphPad

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis